Summary

PT Bio Farma's Covid-19 vaccination spokesperson, Bambang Heriyanto, has clarified that the individual or paid vaccination program is intended for people who have not yet received the first and second doses of the vaccine. The vaccination cannot be used as a booster or third dose. Bambang added that the government has not yet issued regulations on the administration of the third dose. The identities of potential participants will also be checked through the vaccination data information system to ensure that they have not received the first and second doses. The individual vaccination program was scheduled to begin on July 12, 2021, but PT Kimia Farma Tbk (KAEF) has postponed it due to the high public interest and many questions.
The management of Kimia Farma has apologized for the delay and extended the socialization period for the individual vaccination program, as well as the registration of potential participants. The company has reiterated that the paid vaccination program is intended to accelerate the achievement of herd immunity in Indonesia.
The Indonesian government has allowed private companies to conduct individual vaccination programs to help accelerate the country's vaccination rate. However, the program has been criticized for being exclusive and potentially widening the gap between the rich and the poor. The government has also warned that companies that violate the rules will face sanctions.